Tuberculosis News and Research

Latest Tuberculosis News and Research

'Science Speaks' blog reports from 20th Conference on Retroviruses and Opportunistic Infections

The Center for Global Health Policy's "Science Speaks" blog on Wednesday published a series of posts on the 20th Conference on Retroviruses and Opportunistic Infections (CROI), which took place in Atlanta, Georgia, from Sunday to Wednesday.

8 Mar 2013

U.N. FAO head, E.U. development commissioner discuss nutrition, food security with Malawi president

"During a visit to Malawi on Tuesday, the head of the United Nations Food and Agriculture Organization (FAO) and the European Union (E.U.) development commissioner highlighted the need to address malnutrition and food insecurity in the African country, while pledging to work together and support the government in its efforts to this end," the U.N. News Centre reports.

7 Mar 2013

RA patients who initiate anti-TNF therapies do not have higher risk of shingles: Study

Although patients with rheumatoid arthritis have a disproportionately higher incidence of herpes zoster (shingles), an analysis that included nearly 60,000 patients with RA and other inflammatory diseases found that those who initiated anti-tumor necrosis factor therapies were not at higher risk of herpes zoster compared with patients who initiated nonbiologic treatment regimens, according to a study appearing in the March 6 issue of JAMA.

7 Mar 2013

Case of immigrant with XDR-TB shows global vulnerability to infectious diseases, Wall Street Journal reports

The Wall Street Journal profiles the case of a man infected with extensively drug-resistant tuberculosis (XDR-TB) who is being detained in South Texas after a "three-month odyssey through 13 countries -- from his homeland of Nepal through South Asia, Brazil, Mexico, and finally into Texas -- show[ing] the way in which dangerous new strains of the disease can migrate across the world unchecked."

6 Mar 2013

Nursing home patients with pneumonia may need viral screening

Viral testing should be carried out among all older individuals who have been admitted to hospital for nursing home-acquired pneumonia, recommend researchers.

5 Mar 2013

Special envoy for malaria Ray Chambers to help secure investment for achieving health-related MDGs

"Secretary-General Ban Ki-moon has tasked Ray Chambers, who has served as his special envoy for malaria since 2008, with promoting and securing greater investment to achieve the health-related targets within the Millennium Development Goals (MDGs)," the U.N. News Centre reports.

5 Mar 2013

People with variations in FTO gene could be at increased risk of melanoma

The research shows that people with particular variations in a stretch of DNA within the FTO gene, called intron 8, could be at greater risk of developing melanoma.

5 Mar 2013

India needs political leadership, resources to ensure children's right to health

"India is making positive strides in reducing child mortality through new policies and ambitious programs, but preventing the deaths of millions of children remains one of the country's greatest challenges," health expert and blogger John Butler writes in the Wall Street Journals "India Real Time" blog, noting, "Roughly 1.7 million children under five years old die every year in India, says UNICEF, representing more than a fifth of all child deaths worldwide."

2 Mar 2013

Global Fund launches new funding model, says $1.9B available during transition period

"The Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday launched a new funding model that allows it to invest more strategically, achieve greater impact, and engage implementers and partners more effectively," a Global Fund press release reports.

2 Mar 2013

Study identifies six markers in the breath that could become stress-detector

The perennial stress-buster - a deep breath - could become stress-detector, Loughborough University researchers claim. According to a new pilot study, published today, 28 February, in IOP Publishing's Journal of Breath Research, there are six markers in the breath that could be candidates for use as indicators of stress.

1 Mar 2013

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the company's late-stage antibiotic candidate, ceftolozane/tazobactam, as a Qualified Infectious Disease Product (QIDP) for the indications of Hospital-Acquired Bacterial Pneumonia (HABP)/Ventilator-Associated Bacterial Pneumonia (VABP) and Complicated Urinary Tract Infections (cUTI).

1 Mar 2013

Post-2015 development agenda should focus on accelerating progress made against HIV, TB, malaria

"In a little more than two years, the world will hit an important target: the date by which the Millennium Development Goals [MDGs] are meant to be achieved," Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.

28 Feb 2013

Research shows many cancers can be prevented with healthy lifestyle choices

Each year more individuals worldwide die from cancer than malaria, tuberculosis and HIV combined. With research showing that many cancers can be prevented with healthy lifestyle choices, Seattle Cancer Care Alliance is working to raise awareness of preventive tactics in honor of National Cancer Prevention Month.

27 Feb 2013

Examining global efforts against Buruli ulcer

"During my visit to the Médecins Sans Frontières [MSF] Buruli ulcer ward in Cameroon it was wonderful to see the amazing care that the patients receive on a daily basis: antibiotics, state of the art dressings, physiotherapy to help prevent deformities, free food and medicines, and surgery when required," Daniel O'Brien, a specialist adviser with MSF-UK focusing on HIV/AIDS, tuberculosis and Buruli ulcer, writes in the BMJ Group Blogs.

27 Feb 2013

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 210 of its "Global Fund Observer."

26 Feb 2013

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

Avaxia Biologics, Inc., a clinical-stage biopharmaceutical company developing gut-targeted therapeutics, announced today that the first patient has been dosed in a Phase 1b clinical study of AVX-470, an oral anti-TNF antibody, for the treatment of ulcerative colitis.

25 Feb 2013

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

"An intensive campaign to combat HIV/AIDS with costly antiretroviral drugs in rural South Africa has increased life expectancy by more than 11 years and significantly reduced the risk of infection for healthy individuals, according to new research," the Los Angeles Times reports.

23 Feb 2013

With financial commitment, Obama can add 'end of AIDS' to his legacy

"In his State of the Union address, President Obama stated with confidence that the promise of an AIDS-free generation is within our reach," Archbishop Emeritus of Capetown Desmond Tutu writes in a USA Today opinion piece, adding, "We currently possess the power to begin to end a global pandemic that has killed 25 million and infected another 34 million."

22 Feb 2013

Scientists uncover atomic structure of dermcidin

An international team of scientists has discovered how an important natural antibiotic called dermcidin, produced by our skin when we sweat, is a highly efficient tool to fight tuberculosis germs and other dangerous bugs.

22 Feb 2013

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.

21 Feb 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

'Science Speaks' blog reports from 20th Conference on Retroviruses and Opportunistic Infections

U.N. FAO head, E.U. development commissioner discuss nutrition, food security with Malawi president

RA patients who initiate anti-TNF therapies do not have higher risk of shingles: Study

Case of immigrant with XDR-TB shows global vulnerability to infectious diseases, Wall Street Journal reports

Nursing home patients with pneumonia may need viral screening

Special envoy for malaria Ray Chambers to help secure investment for achieving health-related MDGs

People with variations in FTO gene could be at increased risk of melanoma

India needs political leadership, resources to ensure children's right to health

Global Fund launches new funding model, says $1.9B available during transition period

Study identifies six markers in the breath that could become stress-detector

Cubist receives FDA QIDP designation for ceftolozane/tazobactam to treat HABP/ VABP, cUTI

Post-2015 development agenda should focus on accelerating progress made against HIV, TB, malaria

Research shows many cancers can be prevented with healthy lifestyle choices

Examining global efforts against Buruli ulcer

Aidspan publishes new issue of 'Global Fund Observer'

Avaxia initiates AVX-470 Phase 1b clinical study in ulcerative colitis

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

With financial commitment, Obama can add 'end of AIDS' to his legacy

Scientists uncover atomic structure of dermcidin

USP evaluates Raman device's potential to detect counterfeit and substandard medicines

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in